Ceva Animal Health has added a new module to its Cardio Academy website which will provide practical advice on the management of dilated cardiomyopathy in practice.
The module contains an interactive seminar hosted by leading cardiologist and professor of medicine and cardiology at North Carolina State University, Clarke Atkins. The seminar lasts around 30 minutes, after which you're are invited to answer quiz questions relating to the presentation in return for a CPD certificate.
Small animal product manager, Fraser Broadfoot, said: "Our online Cardio Academy is an extremely popular CPD resource that can be accessed at any time, day or night! By using leading specialists, the interactive seminars provide cutting edge and practical advice on a variety of cardiology subjects. We add a new module every month, so check the website regularly."
To access the Cardio Academy please visit www.cardioacademy.cevalearn.com.
Woodley Equipment Company has launched RapidVet-H IC a testing kit for identifying blood types in cats and dogs.
RapidVet-H IC uses immuno-chromatographic technology to identify the feline blood groups: Type A, Type B and Type AB, and the canine blood groups: DEA 1.1 Negative and DEA 1.1 Positive
According to Woodley, this is the first such system to present a positive result as a red line on a white background, thus making it very easy to read.
RapidVet-H IC consists of a hand-held device containing three membranes and uses a diluent specific for these tests. It uses whole blood, or packed red blood cells. It is a cell capture assay, so patients exhibiting auto-agglutination or low PCV can be typed. The system displays results in 5-10 minutes.
For more information about RapidVet-H IC, email: sales@woodleyequipment.com, or call Woodley on +44 (0) 1204 669033 Option 1.
Edinburgh-based charity the Global Alliance for Livestock Veterinary Medicines (GALVmed) has announced three drug discovery contracts in an effort to combat animal African Trypanosomosis (AAT), a disease which is estimated to cost Africa US$5billion a year.
Animal African trypanosomosis, transmitted by the tsetse fly, is a parasitic disease which affects livestock, resulting in a chronic illness which often ends in death. An estimated 50 million cattle and 70 million sheep and goats are at risk, with around 3 million cattle dying annually from the disease.
AAT causes economic losses in livestock, reducing meat and milk production and leaving animals so weak they are unable to help cultivate land. It affects over 10 million square kilometres of fertile land spread across nearly 40 countries in Africa and therefore has a huge impact on food and nutritional security and livelihoods across the continent.
The drugs that are currently used were developed in the 1950s and 60s and drug resistance is now a commonly reported problem. With few other options available, these drugs are the most important method of controlling the disease.
In May 2011 the Department for International Development (DfID) awarded GALVmed 30 month grant for £8million to facilitate the development of drugs, diagnostics and potential vaccines for the control of AAT.
The first contract was awarded to Anacor Pharmaceuticals Inc., a California based biopharmaceutical company established in 2002.
As part of a Drugs for Neglected Diseases Initiative (DNDi) supported project, Anacor and their partners discovered a series of compounds to combat the human form of AAT, Human African Trysanosomsis (HAT). A number of compounds produced under this programme have properties which could make them suitable for the treatment and prevention of animal AAT. These relevant compounds will now be screened for efficacy and safety under the GALVmed contract.
The second and third contracts have both been awarded to the College of Life Sciences at the University of Dundee, one of Europe's top-ranked universities for life science research.
Dr Kevin Read, who is Head of Drug Metabolism and Pharmokinectics at the drug Discovery Unit is leading a piece of drug discovery and development research, which aims to develop new drugs for the treatment and possible prevention of AAT in cattle, and also a diagnostic test for use in the field. This builds on the university's work on HAT and drugs that were unsuitable for human treatment are now being re-evaluated as potential drugs for cattle.
Dr Read said: "I am very excited to be working in partnership with GALVmed to apply our extensive drug discovery expertise in HAT to identify and bring forward new potential drugs for the treatment and prevention of AAT. The new project offers an exciting opportunity to reposition compounds showing great promise for the treatment of first stage HAT into AAT, thus improving food security in some of the poorest countries in sub-Saharan Africa."
BCF has announced a number of special deals available on a variety of ultrasound and X-ray products.
With the launch of the new Mindray DP-50 ultrasound scanner, available exclusively from BCF, the company is offering a free trolley and a year's supply of gel.
If you buy a Carestream Vita CR X-ray system and generator from BCF, the company will update your X-ray protection with 3 gowns and 2 thyroid protectors (worth £600, €750) free.
Purchase an Easi-Scan with one battery, and you'll get a second battery and carry bag for free.
Buy an equine DR X-ray system and you'll receive £1,000 (€1,250) to spend on Podoblocks accessories.
Call +44 (0)1506 460 023 or visit www.bcftechnology.com for further information. Offers valid until 31st June.
Merial Animal Health has announced the launch of its new feline vaccine Purevax Rabies in the UK and Ireland.
Merial says the product offers a simple but elegant solution to rabies vaccination, without the need for adjuvant. According to the company, the non-replicative vector is processed by the cat's immune system in the same way as a live virus, triggering both a powerful cell mediated and humoral response without the need for adjuvant. However, because the vector cannot replicate effectively in mammalian cells, there is no risk of any reversion to virulence.
Merial's Veterinary Technical Manager Kevin Whelan, said: "This is a perfect complement to our existing range of advanced technology vaccines, which already offer the benefits of highly effective protection, including updated FCV strains, without the need for adjuvant. It also represents Merial's continued commitment to the development of innovative products for the animal health market".
The vaccine is licensed for use in cats from 12 weeks of age, and administration of a single injection has been shown to provide protection against disease.
Contact your local Merial Representative or the Merial Technical Support line on 0870 6000 123 for further information.
A Europe-wide survey has found that speed and accuracy are the key features that farm animal veterinary surgeons and farmers want from diagnostic tests
More than 334 individuals from 8 countries were asked about their current usage and knowledge of diagnostics, and asked what they would like to see in the future. Greater accuracy was the number one need among veterinary surgeons, mentioned by 37%, followed by more speed (22%); cost savings (16%) and greater confidence in the results (8%) were other features that they would like to see improved.
The survey, which was commissioned by global biotechnology company Life Technologies, showed that most test results are currently available in one to three days, but still a significant proportion have to wait three to six days for results (39%) or even more than six days (20%). Only 10% currently get their results within 24 hours.
Although many of the vets were aware of modern molecular diagnostics tests such as PCR (polymerase chain reaction) which generally offer quicker results than culture testing, most did not know which were used most often. The vast majority of farmers were happy to leave the decision on type of diagnostics test to their veterinarian.
Frederic Bar, Sr. Marketing Manager EMEA at Life Technologies said: "The results show that veterinarians are looking for the speed and accuracy that modern molecular diagnostics, such as PCR, can provide, but this technology is still not being used as widely as it could be."
"One way in which veterinarians could get faster, more accurate-results would be to specify PCR when they submit samples to diagnostic laboratories.
"Diagnostics have really moved on in recent years and the modern tests can give very reliable results, often in just one day, so veterinarians and farmers can make herd health decisions more quickly."
The survey found that BVD, IBR and MAP tests were the most commonly used in cattle, while PRRS, Influenza A and Salmonella topped the list for swine. For sheep and goats, Salmonella, MAP and Chlamydia were the most frequently mentioned tests; for horses, EHV, equine infectious anaemia and Salmonella were most common. Avian influenza was by far the most commonly tested disease in poultry.
Clinicians at the Queen Mother Hospital for Animals at the Royal Veterinary College have become the first team in the UK to successfully treat acromegaly in a cat with hypophysectomy surgery.
According to the RVC, this make it the first centre in the UK, and only the fourth in the world, to offer this procedure. The patient groups that might benefit from this RVC-exclusive procedure include cats and dogs with non-functional pituitary tumors, cats and dogs with hyperadrenocorticism (Cushing's disease) and cats with acromegaly or hypersomatotropism.
The RVC says removing the pituitary gland and the associated tumour which causes acromegaly or hyperadrenocorticism is the gold standard treatment in humans suffering from these diseases since it offers the greatest chance of a complete cure for the disease.
Prior to the RVC offering surgical treatment, the only treatment options available for acromegalic cats in the UK were radiation therapy or simply treatment of the resulting diabetes mellitus. The latter can prove extremely difficult and frustrating and the former unpredictable, unreliable and/or ineffective. Even when a complete response to the radiation therapy eventually occurs, hormonal abnormalities usually persist.
Dr Stijn Niessen, leading the hypophysectomy team at the Royal Veterinary College, said: "I'm extremely proud to be able to offer this unique surgery for the first time in the UK at the RVC. As a relatively new and innovative procedure in veterinary medicine there are risks involved, as is recognised with every form of neurosurgery of this level. However, despite these risks, this surgery does offer owners a chance for the best possible result for their pet using a single procedure. Hypophysectomy therefore represents the most elegant treatment method currently available enabling complete removal of the brain tumor and normalisation of damaging excessive hormone levels that are causing hormonal diseases like acromegaly and hyperadrenocorticism.
"Especially when a pituitary tumor is diagnosed late, the alternative treatment method of radiation therapy might well take too long to take effect and devastating neurological signs might occur due to the pressure of the pituitary tumor on the surrounding brain. In such cases, hypophysectomy can make an instant difference in relieving that pressure. However, in general, we would advocate the procedure to be considered as soon as possible following diagnosis, thereby preventing the animal's body from becoming more and more negatively affected by the excessive hormone levels associated with pituitary diseases like acromegaly and hyperadrenocorticism."
Dr. Niessen, a European Veterinary Specialist in Internal Medicine with research interests in diabetes and endocrinology and world-expert in acromegaly, will be selecting the patients suitable for the new treatment, preparing them for surgery and managing the aftercare programme. The longer-term aftercare programme will include hormone replacement treatment administered through eye-drops (usually temporarily) and tablets (permanent) to manage the hormone production lost through removal of the pituitary gland.
The surgery itself will be performed by Patrick Kenny, a European and American Specialist in Veterinary Neurology and Neurosurgery.
The RVC says the surgery would not be possible without the multidisciplinary approach at the Queen Mother Hospital for Animals, which includes the Internal Medicine, Neurology and Neurosurgery, Diagnostic Imaging, Anaesthesia and Emergency and Critical Care teams as well as a team of highly qualified nurses.
To support ongoing research in this field, the Royal Veterinary College is offering free blood tests for all diabetic dogs and cats which include fructosamine evaluation and screening tests for the presence of acromegaly in cats. Cats that record high hormone levels indicative of acromegaly will qualify to undergo a free CT scan for confirmation. If acromegaly is confirmed, all possible treatment options will be discussed with the client, including the hypophysectomy procedure. To request a free blood test for a patient please visit: www.rvc.ac.uk/cic
Veterinary surgeons currently managing a cat or dog with a pituitary tumor who are considering referral of this case can also contact Dr Stijn Niessen for further information at the QMHA on 01707 666365 or at qmhreception@rvc.ac.uk
The Federation of European Companion Animal Veterinary Associations (FECAVA) has launched the European Journal of Companion Animal Practitioners (EJCAP) Online, the first European fully online veterinary journal.
As the official journal of the FECAVA, the EJCAP online is exclusively available to members of national companion animal veterinary associations which are in turn members of FECAVA (which include the BSAVA).
According to FECAVA, the EJCAP online will continue to offer the sort of high quality CPD articles which the magazine was known for during its 21 year history in print. However it will now also be able to offer rich media, such as videos with clinical presentations, endoscopy and ultrasound recordings, diagnostic and surgical techniques, interviews with experts, conference presentations as well as slide shows, interactive quizzes, surveys and animations.
The frequency of publication has also been increased, from three to four issues per year, including one special issue.
The EJCAP online is available in two languages - English and Spanish. More languages are planned in future.
Simon Orr, FECAVA president, said: "Since the momentous decision to publish EJCAP online was taken by our Council in Lille in 2009, we are delighted to offer our members this new and engaging way to gain new information and skills.
As we start work on the next issues, we invite all our readers to give us feedback on this first volume of EJCAP online. On the last spread (page) there is a link to a survey on this new format, to help us further improve and optimize EJCAP online."
To register, visit EJCAP online (www.fecava.org/ejcap).
Supreme Petfoods has announced that Think Rabbit Fortnight, a campaign to help practices engage with rabbit owners, will run from Monday 21st May to Friday 1st June.
Practices can decide how much they wish to participate in the campaign and can opt to receive goodie bags, a 'Think Rabbit' manual detailing how the practice can be more rabbit-friendly, or take the 'Small Furry' Promise.
The event is being backed by RCVS Exotics Specialist, Molly Varga. She said: "I'd encourage all practices to take part in Think Rabbit Fortnight to help improve the health and welfare of the nation's rabbits."
Supreme says that practices which take part in the Think Rabbit Campaign will also have the opportunity to sign up for Level 1 of its 'Better for Bunnies, Better for Business' programme, which it says can double turnover derived from rabbits through an increase in new clients, average visit transaction spend and attendance rates of existing clients.*
Claire Hamblion, Marketing Manager at Supreme says she hopes that it will really encourage practices to focus on how they can develop protocols and routines that will remove barriers to rabbit owners seeking healthcare advice and presenting their pet for treatment.
Binky - voted Britain's Cutest Bunny - will play a starring role in the Think Rabbit campaign to attract the attention of rabbit owners who will also be asked to nominate their rabbit as a VIP (Very Important Pet). Claire said: "Our VIP won't necessarily be the most prettiest, fastest or cleverest bunny but one that has special qualities in the eyes of its owner. I hope vets and nurses will help spread the word and maybe even nominate some very important patients."
To sign up for Think Rabbit Fortnight, visit www.supremepetfoods.com/thinkrabbit, email thinkrabbit@companionconsultancy.com, or telephone 01284 761107.
*Supreme - Better for Bunnies, Better for business programme, Onswitch March 2012
Research commissioned by Bayer Animal Health has revealed that dogs really do look like their owners.
The research, which is being used to promote Drontal Bone, the company's new bone-shaped wormer, was conducted amongst 3,000 British dog-lovers. It found that the overwhelming majority of owners share at least one common physical attribute with their pet, whilst one in ten owners could be described as the spitting image of their dog, sharing six or more physical attributes:
As part of the campaign, Bayer has launched the Give Your Dog a Bone competition, a nationwide search to find the UK's "Top Dog". The competition is split into four video and photographic categories, with one open exclusively to dogs that have formed a special bond with their owner. Top dogs can enter via the competition website - www.giveyourdogabone.co.uk - where owners can upload photos, videos, and explain in under 100 words why they think their pet should win a Drontal 'Bonies' award.
Give Your Dog a Bone Judge Emma Milne MRCVS, said: "When dogs seem to have the same characteristics as their owners, it could be because people subconsciously choose a pet that resembles themselves. It is often found that more energetic breeds, such as s Red Setter have an owner who is sporty and most happy when taking their pet on long country walks, while a glamorous owner who enjoys grooming themselves might choose a dog which also requires lots preening, such as a Maltese Terrier. The Give Your Dog a Bone awards give us the chance to recognise the unique traits and talents that make dogs such an important part of our lives. With four very different categories, this competition will be wide open to dogs of all shapes, sizes and personalities!"
Dechra has launched a two hour online CPD session on skin and ear cytology for veterinary surgeons and nurses.
The module was created in conjunction with Peter Forsythe BVM&S DVD MRCVS RCVS Specialist in Veterinary Dermatology.
Senior Brand Manager at Dechra Veterinary Products, Larry King, said: "Cytology is a key to diagnosing otitis externa, a common condition seen by vets and nurses but one which can be challenging to manage.
"Carrying out cytology will assist them in deciding on the appropriate approach to control the infection. Our online CPD module, presented through a series of videos, will explain cytology step by step from initial presentation to organism identification."
Peter Forsythe added: "It is difficult to practice good dermatology without doing cytology, which is inexpensive, quite quick to do and is a great aid in the diagnosis of skin disease. These videos cover the investigation of pyoderma, Malassezia and otitis externa, but actually this is just the tip of the iceberg and the same techniques can be used for investigation of a range of other inflammatory skin diseases."
The free of charge CPD, available at www.dechra.co.uk/academy, includes downloadable resources and a short quiz to support the module, with a certificate upon completion.
The Royal College of Veterinary Surgeons has announced the results of the RCVS Council and Veterinary Nurse Council elections.
A record number of candidates stood in the RCVS Council election this year, and the results were much closer than usual.
Two candidates entirely new to the Council have been elected, one of whom - Amanda Boag - received the highest number of votes. The other - Chris Barker - also did well, coming in third place overall.
Three existing RCVS Council Members have been re-elected for a further four years, and Stephen May, who was formerly an appointed Council Member from the Royal Veterinary College, was also voted onto Council for the first time.
Of the three candidates standing for election to VN Council, one existing Member - Kathy Kissick - has been returned, and one new member - Elizabeth Figg - has been elected.
All successful candidates will take up or resume their seats at RCVS Day on 6 July 2012.
Turnouts for both elections remained low, with just 3,625 veterinary surgeons (15.1%) and 743 veterinary nurses (7.5%) choosing to exercise their right to vote.
By comparison, in 2011 voting figures were 3,887 (15.9%) and 723 (7.6%), respectively.
Veterinary surgeons' and veterinary nurses' use of online and text voting, rather than postal voting, increased again this year from 25% to 30.6%, and 12.9% to 20%, respectively.
Woodley Equipment has launched ImmunoComb diganostic test kits for FIP, canine Leptospira and Ehrlichia
Woodley says the kits are easy to use and provide results within 20 minutes. No specialist laboratory equipment is required as the kits are self-contained with all the necessary reagents. The diagnostic kits determine the animal's antibody titre levels, in the case of the canine Ehrlichia as early as 7 days after infection, giving veterinary surgeons the opportunity to act more quickly in developing a prevention/treatment program.
Tests can be performed singly or up to 12 simultaneously.
For more information about ImmunoComb Diagnostic kits email sales@woodleyequipment.com or call: +44 (0) 1204 669033 Option 1. Alternatively visit http://www.woodleyequipment.com/
The British Veterinary Nursing Association and the Society of Practising Veterinary Surgeons have launched a waiting room poster to help practices raise awareness of the status of their VNs and promote the welfare benefits that VNs can help provide.
Rolled copies of the A2 posters are available in a tube for £2.50 (to cover postage). Folded copies are free or you may download the poster here.
Contact the BVNA office on 01279 408644 to request a copy.
Bayer Animal Health has organised for prominent clinical microbiologist Dr Joseph Blondeau, from Canada's University of Saskatchewana, to tour the UK in May, giving talks to practitioners about effective antibiotic usage to prevent bacterial resistance.
Bayer's Technical Veterinary Adviser, Lucy Smith, will also be giving a talk: Maximise Treatment Success, which comes at the subject from the practical veterinary side.
Bayer Animal Health Marketing Manager, Dr Markus Edingloh said: "We are incredibly fortunate to work with such an eminent expert. Dr Blondeau is a leading authority on a new parameter that supports a dosing concept to minimise selection of bacterial resistance - the Mutant Prevention Concentration. Fortunately, he is also expert at presenting complex matters in an engaging and memorable way."
He added: "Lucy Smith will share her specific experience of Bayer's recently launched Veraflox (pradofloxacin), the first and only next generation veterinary fluoroquinolone, which has a broad spectrum of treatment which attacks Gram +, Gram - and anaerobic bacteria, in a highly efficacious way.
The evening events take place on: May 14th (Glasgow), May 15th (Derby), May 16th (Swindon) & May 17th (Surrey). Full details in the VetSurgeon Diary.
Each roadshow session is equivalent to 1.5 hours of free Continuing Professional Development (CPD).
To register to attend one of the roadshows, please email animal.health@bayer.com
US-based Life Technologies has launched a new PCR-based test system which, according to the company, allows large numbers of pigs to be screened more quickly and cost-effectively for a range of common pathogens, such as PRRSV, SIV and PCV2.
The system uses samples of oral fluids which can be obtained by leaving a cotton rope in each pen for pigs to chew on. After 20 minutes or so, the rope can be retrieved and the saliva and gingival crevicular fluid squeezed into a sample bag and represents a pooled sample from the group.
Studies have demonstrated that oral fluid samples collected in this way can form the basis of a quick and cost-effective method for screening a range of common viral pathogens. The samples were tested using a commercially available sample preparation and real-time PCR test system which can isolate and identify viral nucleic acid in a matter of hours.
For PRRS, pooled samples of oral fluids were collected from groups of experimentally infected pigs using the rope technique, along with serum samples from each individual pig on the same days. Both serum samples and oral fluids were processed using the same Applied Biosystems preparation system and real- time PCR test, both of which were supplied by Life Technologies. The results showed that PRRSV nucleic acid was detectable in both serum and oral fluid samples from the day of infection through to 40 days after infection.
For PCV2, 24 pigs that were free of PRRSV and SIV were divided into 4 pens in separate rooms, and challenged with two different virus strains (PCV2a and PVC2b) at different times. One pen acted as a (non-challenged) control. Oral fluids were collected regularly up to 140 days after initial challenge and tested using real-time PCR. High titres of PCV2 were detected from day 12 to day 28 post infection and virus was detectable throughout the entire testing period (days 2 to 98).
For SIV, a total of 180 spiked oral fluid samples were tested using real-time PCR, and subtyping reagents were also used to identify haemagglutinin and neuraminidase subtypes. The results showed that SIV nucleic acid was detectable in oral fluid samples spiked with high, medium and low copy numbers of SIV, and all positive samples could be successfully sub-typed.
Christina Boss, European Professional Service Veterinarian for Life Technologies said: "Collecting samples in this way is far less invasive for the pigs and so avoids unnecessary stress. And because all of the pigs will chew on the rope, it provides a very broad sample from the group, which is the key to assessing overall herd health. In addition, if the pooled sample provides a positive result, then the animals in that pen can be tested individually to identify those that are infected.
"These results show that the simplicity of oral fluid sampling, combined with the speed and sensitivity of a PCR-based system, provides a practical and cost- effective way of monitoring large numbers of pigs for common virus pathogens.
"The use of a semi-automated, PCR-based diagnostic system means that nucleic acid purification can be achieved in just 25 minutes and results from the real-time PCR available in 90 minutes. The molecular test is very specific and reliable, so the veterinarian can initiate individual testing as quickly as possible and make confident recommendations to the producer."
According to Life Technologies, screening for PRRS using samples of oral fluids has been gaining popularity over recent years because large numbers of pigs can be tested without increased cost or labour. The new research is due to be presented as a poster at the ESPHM meeting in Bruges in April.
Pfizer Animal Health, maker of the equine wormers Equest and Equest Pramox, has unveiled www.wormingyourhorse.info, a new website which aims to make it easier for horse owners to understand and follow the most up-to-date principles of sustainable worm control.
Based on the company's Manage, Test, Plan, Dose campaign, Pfizer says the new website is designed to take the confusion out of equine worm control with clear, logical and easy-to-understand guidance and advice.
The four main sections use diagrams and text to explain how and why it's important to manage the worm challenge on the pasture; the role of faecal worm egg counts (FWECs); how history and management play a part in planning the best worm control programme and how to choose and use the right wormer at the right time of year.
There's an interactive and educational parasite page that shows the parasites that can affect the health of your horse. There are click through buttons on parts of the horse's anatomy revealing details about the appearance of each particular parasite, their lifecycle and the symptoms they can cause. In addition there's a section on frequently asked questions which provides no-nonsense answers to some of the most commonly asked questions about worm control.
Paul Blanc, Pfizer's equine brand manager said: "In developing our new website we have listened carefully to what horse owners really want and need to know. The result is a source of plain-speaking, unbiased facts and advice, providing horse owners with the most current thinking on sustainable worm control in a format they can really identify with."
Woodley Veterinary Equipment has launched a range of eight veterinary stains.
The company says that the range offers a comprehensive product base to suit most requirements, and that they are all quick and easy to use.
The range is made up of the following individual stains for single test use:
Also available is the Automated Slide Stainer, which Woodley says is capable of precise, balanced slide stains for use with Haematology and Gram staining. Maintenance free and self-cleaning the Automated Slide Stainer is also programmable for individual preferences.
For more information, email: sales@woodleyequipment.com or call Woodley's customer service team on +44 (0) 1204 669033 Option 1. Alternatively visit www.woodleyequipment.com
The RCVS is advising all practices that it is not currently carrying out a data-gathering exercise and that phone calls prompting the return of a survey, and requesting mobile phone numbers, are not being made on behalf of the College.
The warning comes after several practices have called the College to query 'feedback forms' - supposedly issued in relation to the Practice Standards Scheme or the payment of members' retention fees.
The practices were asked to return forms which they had not received, and also to provide mobile phone numbers, by someone who claimed to work for the 'statutory regulator' or 'the RCVS'. Contact phone numbers left by the caller were either RCVS fax numbers or numbers which looked like RCVS direct dial numbers, but were not.
Lizzie Lockett, Head of Communications, said: "This looks like an exercise to gain mobile phone numbers which is being carried out in the College's name. We are currently investigating who might be making these calls. In the meantime, if a practice receives such a call, it would be helpful if they could take down a name and contact number and let us know."
Ring 020 7202 0725 or email l.lockett@rcvs.org.uk to report any suspicious activity.
The Government has announced that it is extending existing dangerous dogs laws to apply to private property, closing a loophole in the current law which only applies to public land.
Jim Paice, Minister of State for Agriculture and Food, said: "We've all heard the stories of snarling dogs not being properly kept under control or heard from health workers, postal workers or social workers who are at risk of serious injury from out of control dogs while just doing their job, attending to people in their homes.
"Today we are announcing a comprehensive package of measures that tackle the problem head on, which will better protect legitimate visitors to private property and will enable the police to take action before someone is hurt or killed."
The plans also put forward proposals to allow the police, when dealing with any dogs which are subject to proceedings under the Dangerous Dogs Act, to take a common sense decision as to whether the dog really needs to be kept away from their owners until the outcome of proceedings.
Mr Paice added: "Our plans must strike the right balance between protecting the public from dangerous dogs and ensuring that safe and properly looked after pets don't need to be wrenched from their home unnecessarily.
"We're giving the police more discretion to take common-sense decisions where dogs are clearly not a threat by ending the requirement that they be seized and kennelled, at great cost to the taxpayer and distress to the owner involved, while a decision is taken on whether to exempt the dog from being destroyed under the Dangerous Dogs Act."
Other measures announced today include:
However, the proposals do not go far enough for Dogs Trust, the dog welfare charity. Clarissa Baldwin, the charity's CEO said: "The Government has spent a great deal of time examining this legislation since it came to power and whilst we accept DEFRA has done their best to look at this issue, unfortunately, their best is no where near good enough. Not good enough to better protect the public or good enough to improve animal welfare.
"Government must tackle this problem head on with completely new legislation rather than just tinkering around the edges. We're extremely disillusioned that there is nothing in the consultation on measures that will actually help to prevent dog attacks, which is surely what the aim of these proposals should be. We seem to be waltzing along on this issue rather than the quick step we need to meaningful reform.
"We consider that the introduction of compulsory microchipping of all dogs, not just those born after a certain date, is the only way that we will see immediate welfare benefits and a reduction in the number of stray dogs in the UK.
"Microchipping will not prevent dog attacks but it will allow the owner of a dangerous dog or a dog that was dangerously out of control to be identified by enforcement agencies. The act of microchipping is also a key intervention, providing an opportunity to advise owners about responsible dog ownership and the law."
BSAVA Congress was invaded by Orangemen this year to promote the Vet Charity Challenge (VCC) taking place on 15th September 2012.
Veterinary surgeons and industry colleagues are being encouraged to take part in the one day event in which teams of four will complete a series of physical tasks and puzzle-solving challenges. Teams can choose their own routes which include walking / running, cycling and kayaking stages and can make it as easy or hard as they like.
The Vet Charity Challenge is hoping to raise in excess of £20,000 for Hounds for Heroes; SPANA, and Pet Blood Bank. VCC says it will be a great PR opportunity for practices and an opportunity for team-building.
The event will take place at the Royal Agricultural College, Cirencester and all details may be found on www.vetcharitychallenge.co.uk or by phoning 01727 859259. The VCC will provide training guidelines and sponsorship forms. Places are limited so early booking is advisable. To be sure of a place, practices and business are urged to book their team of four by the deadline of Friday 29th June 2012.
The Vet Charity Challenge is sponsored by BCF Technology, Kruuse UK Ltd and Vets2.net and is supported by the VPMA, Mojo Consultancy and JCA Media Group.
Elanco Companion Animal Health, maker of Comfortis chewable tablets for dogs, has launched a range of support materials to help educate pet owners on flea infestation and the healthcare issues associated with fleas and encourage enquiries about flea control solutions.
The Range of Comfortis materials features point of sale equipment including free-standing zig-zag display units, window hanging displays, stacking cubes, freestanding easels and leaflet holders as well as client leaflets, waiting room display kits, posters and 20% discount letterheads and postcards for mail-outs. An animation (shown below) is also now available in various formats for veterinary practices to use on their waiting room monitors or websites. The animation, which aims to educate dog owners on flea infestations and complications, covers common risk factors for flea infestations, flea facts including the lifecycle of the flea and encourages pet owners to ask for further information on oral flea control options.
Matthew Rowe, senior product manager at Elanco Companion Animal Health said: "With many pet owners seeking their flea control solutions from other sources, such as the increasingly competitive pet superstores, veterinary businesses need to provide unique preventative healthcare services to their clients to help bond them to the practice and ensure that they return again and again. The new Comfortis support materials will help raise client awareness of the benefits of veterinary prescribed flea treatments and thereby help differentiate veterinary practice flea control solutions from those available in country stores, pet shops, supermarkets and pharmacies."
For further information on Comfortis, or the range of support materials, contact your Elanco Companion Animal Health key account manager or email elancocah.uk@lilly.com.
The RCVS Disciplinary Committee has dismissed charges of serious professional misconduct against a veterinary surgeon and former employee of Medivet (Watford).
Tomasz Nazimek, who qualified in Poland in 2001 before starting work in England in 2005, was alleged to have charged for the use of a blood pressure monitor during an exploratory laparotomy on a cat called Mitzi, whilst working at the Watford branch of Medivet in June 2009, when he knew, or ought to have known, it had not been used.
Despite his previous signed statements to the contrary, Mr Nazimek admitted at the outset of the hearing that no blood pressure monitor had in fact been used.
Accordingly, the Committee only had to establish whether Mr Nazimek himself had entered the fee for its use into Mitzi's records and, if so, whether this was done dishonestly.
The alleged incident came to light as a result of a covert investigation into Medivet conducted by the television production company Fulcrum TV in 2008/9, and subsequently commissioned by the BBC and broadcast in July 2010 as part of the Panorama programme 'It Shouldn't Happen at a Vets''.
Former dental nurse Alexandra Lee was employed by Fulcrum TV as an undercover reporter to work as a 'trainee veterinary nurse' at Medivet, in order to record audio and video footage of her experiences there.
The case against Mr Nazimek was based partly on a conversation overheard by Miss Lee following the operation on Mitzi, where she maintained that Guy Carter, a senior Medivet partner and veterinary surgeon, told Mr Nazimek (who was sitting at the practice computer typing up Mitzi's records) not to forget to include a fee for use of the blood pressure monitor.
However, Miss Lee's equipment had not recorded this exchange, due to a fault, and her video diary of that day's events was not put in evidence before the Committee. Miss Lee also accepted in evidence that she had not actually seen who entered the fee into the records, but had assumed it was Mr Nazimek.
Despite giving serious consideration to all of Miss Lee's evidence, the Committee found it of limited value.
The Committee considered the statements signed by Mr Nazimek, but prepared for him by the Medivet senior management in December 2009 and October 2010, which stated that he had used the monitor, consulted Mr Carter about charging for it and then added the fee himself.
The Committee also considered a third statement provided to the College (September 2011), in which Mr Nazimek recalled that Mr Carter had priced up the operation himself, but not asked for his input.
When questioned about the discrepancies in his statements, Mr Nazimek told the Committee that he had confused different operations and now knew his earlier statements to be wrong.
He indicated that he had been under pressure from his then employers to sign the statements, that his attempts to change them were ignored by Medivet's managing partners and that he was depressed and under stress at the time.
He was not told that the statements could be in relation to charges against him, or that he was entitled to legal advice when discussing them with his employers.
The Committee found Mr Nazimek's oral evidence to be persuasive, his manner open and his responses under cross-examination frank.
In the absence of satisfactory and reliable evidence to the contrary, and in view of supportive testimonials provided from his current employer and former colleagues as to his honesty and integrity, the Committee found Mr Nazimek's repeated assertion that he did not make a charge for the monitor "entirely plausible" and believed that he told the truth.
Nevertheless, the Committee emphasised that a charge for the monitor had been entered into the records when no such device had been used, which it regarded as unacceptable.
Speaking on behalf of the Committee, Chairman Professor Peter Lees said: "The Committee is not satisfied by the evidence so that it is sure that [Mr Nazimek] entered into the records for Mitzi a charge for the blood pressure monitor. [It] believes that [Mr Nazimek] told the truth when giving his evidence and the character references support his honesty.
"In these circumstances, it is not necessary to consider the charges further and the allegations against [Mr Nazimek] are dismissed."
Pfizer Animal Health is offering the chance to win £500 worth of CPD vouchers to UK veterinary surgeons who participate in the company's 5 minute online survey about Equine Herpes Virus (EHV).
Pfizer says the intention of the survey is to find out more about veterinary perceptions and understanding of this endemic disease and its effects on the UK's valuable equine industry. There are five multi-choice questions and the survey is available online from now until 31st May 2012. Vets who show their prowess in the skills-based section of the survey will be entered to win £500 of British Equine Veterinary Association CPD vouchers.
The survey is part of Pfizer's EHV awareness campaign to help vets encourage horse owners, yard managers, trainers and breeders to keep their horses protected from the effects of this common but often under-prioritised disease. The campaign includes the provision of information leaflets and the coordination of talks to help people, who manage horses, understand the severity of EHV and the best ways to prevent it.
According to Pfizer, the prevalence of EHV can be as high as 87.5% in the UK and latent infections in horses are frequently re-activated.1,2 The consequences can be serious, with abortion outbreaks proving to be a significant economic burden to owners, trainers and breeders.3,4 However, subclinical infections, although usually regarded as less serious, can remain unrecognised and can cause suboptimal performance in horses.
Sporadic, mild respiratory disease caused by EHV can lead to interrupted training and movement restrictions.4 Even after clinical recovery from EHV-1 or upper respiratory tract infections caused by EHV-4, some horse may develop 'poor performance syndrome'.5 These can all have serious financial repercussions on the equine industry.
To take part in the survey, visit http://www.ehvaware.com/. For further information on Pfizer's EHV campaign, to obtain literature for your practice or to book a talk for your clients please contact your Pfizer Account Manager.
1. Eddington et al. Equine Vet. J. 1994; 26 (2): 140-142. 2. Allen GP. 2002. Respiratory Infections by Equine Herpesvirus Types 1 and 4. In: P. Lekeux ed. 2002. Equine Respiratory Diseases. New York: International Veterinary Information Service. 3. Garré B et al. Vet Microbiol. 2007; 122(1-2): 43-51. 4. Lunn DP et al. J Vet Intern Med. 2009; 23(3): 450-61. 5. Slater, J. 2007. Equine Herpesvirus. In: Sellon, D. and Long, M. Equine Infectious Diseases. St Louis: Saunders. 144.
The University of Bristol and Companion Care have launched The Great Pet Travel Survey 2012 to assess disease risks in the UK following the simplification of Pet Travel Scheme rules.
Companion Care and The University of Bristol say that there is a great deal of concern about what risks changes in the Pet Travel Scheme Rules pose to the health of the human and dog population in the UK.
Robert White-Adams MRCVS from Companion Care said: "At present there is minimal data available to answer this question as current data logging is minimal and paperwork checking at ports can be variable. We therefore have little idea of how many UK-resident dogs travel abroad, where they visit, how long they stay and what they are doing whilst abroad.
The survey will collect and analyse information about the travel patterns of UK resident dogs, in and around mainland Europe, over the last decade.
Robert added: "The data to be collated by the survey will fill the data void and enable us to provide a quantitative assessment of the disease risk, as well as gaining an understanding of owner awareness of risks face by dogs travelling in Europe.
Owners of dogs with Pet Passports are being encouraged to fill in the short questionnaire, which is available now at http://www.greatpetsurvey.co.uk/. All completed questionnaires will be entered into a prize draw to win £100 of Pets at Home vouchers!
The questionnaire will be live online until 30th June 2012 and all data will be analysed by the University of Bristol.
Dr Morgan said: "Without this information we have only a vague idea of the risks that the loss of border controls may pose. The answer could be that there is little additional risk or it could be that the UK dog (and human) population could face some severe disease threats. As it stands now, we just don't know enough to make an informed judgement."